How can you deal with a virus that has the capability of even switching its entry route?
Laboratory experiments demonstrate that #Omicron has switched its route of entry in to human cells. 1/
This is likely to influence #Omicron spread and the types of cells it can hijack. 2/
#SARS2 can enter cells via two routes, both routes require spike activation by proteases.
Route 1: Cell surface fusion, triggered by #TMPRRS2.
Route 2: endosomal fusion, triggered by cathepsins.
So far SARS2 has favoured Route 1. 3/
There is strong evidence of a dramatic switch in #Omicron entry route from cell surface to endosomal fusion. 4/
Omicron has shifted from a TMPRSS-2-dependent fusion at the cell surface, to a cathepsin-dependent endosomal fusion. So, the preferred entry mechanism of Omicron is different now (ie, it's a big big big change). 5/
Another consequence of this switch is that #Omicron can no longer mediate TMPRSS2-dependent fusion of infected cells with adjacent non-infected cells. So reduced fusogenicity may not hamper its infectivity! 6/
Omicron may be deficient at syncytium formation but it can move to other cells better than previous thru enhanced endosome fusion.
This sort of thing could affect tissue tropism, the tendency of a particular variant to invade a particular organ or not. 7/
These discoveries may have implications for the tissue preference of #Omicron and for viral transmission. 8/
These results were confirmed by other researchers too with the freshest results by @PeacockFlu and team. 9/
@PeacockFlu proposes a model where Omicron has become less specialised in its entry route and become more of a 'generalist' - this allows it to efficiently infect a greater number of cells in the upper respiratory tract and may mean it even has a lower infectious dose? 10/
@PeacockFlu also concludes that Omicron Spike is more able to use the endosomal entry route than previous variants, being less sensitive to TMPRSS2-mediated entry and more sensitive to inhibitors of endosomal entry. 11/
We all know about the ‘furin cleavage site’ (FCS) at S1/S2 junction. Similar to this FCS, the 637 cathepsin site is located in a flexible loop region, which would allow cleavage. 12/
It will be important to tease out what the drop in TMPRSS-2 cleavage & the increase of importance for cathepsin-dependent entry causes in #Omicron. If it is due to epistatic effects by several mutations the reversion is likely a multi-step process. 13/
And if this could change back to a TMPRSS-2 use and likely associated pathogenicity in a much easier way?? this is purely speculative at this point.
14/
The new findings on Omicron’s preferred way of entry to the host cell led to new sketches 👇
• • •
Missing some Tweet in this thread? You can try to
force a refresh
What happens if we allow #SARS2 to become endemic? What’s going to happen to us & what’s going to happen to the virus?
If we allow it to become endemic—and some would argue that it is already endemic—this does not mean that it is going to attenuate, not whatsoever. 1/
It is not true that more transmissible versions of #SARS2 will be more benign. What we are seeing is more aggressive, more transmissible versions which are creating more severe illness. And the virus is still adapting to our physiology. It’s doing it at a fantastic rate 2/
What we’re going to see is that it will continue to work against our immune systems, meaning become more immune evasive. It’s going to become more chronic as an infection. 3/
Booster effectiveness against breakthrough coronavirus infection is already waning.
The protection against infection among Pfizer booster recipients ages 60+ topped out by day 30 then fell steadily. 1/
By day 58, the #booster appeared to be providing around 40% of the maximum increased level of protection above the initial 2-dose series.
New data finds boosters are helping more than just 50+, but that the effects already appear to be decreasing. 2/
Bottom line: The case for boosters to prevent infection for all adults is now far stronger, if that is our goal. But how long that protection lasts remains unclear at best and boosters may turn out to lower the #Ro of #SARS2 only briefly. 3/
1-Vaccination reduces transmission of #Delta, but by less than #Alpha
2-Alpha: Pfizer 62%, AZ 38% reduction
Delta: Pfizer 37%, AZ 15% reduction (aOR)
3-The impact of vaccination decreased over time 1/
4-Vaccinated people with breakthrough infections were less likely to spread Covid.
5-Vaccination not only reduces the risk of becoming seriously ill from the virus, it also protects those around you. 2/
6-Contacts of vaccinated cases were less likely get Covid than contacts of unvaccinated cases.
7-Most transmission occurred in households, showing that vaccination can protect household members—including kids not yet eligible for vaccination. 3/
No doubt, #molnupiravir is touted as a ‘game changer’ as far as therapeutics against #SARS2 are concerned. But the news related to its probable #mutagenic potential comes as a dampener 1/
#rNHC, an active metabolite of #Molnupiravir, inhibits SARS2 replication in cell cultures through lethal mutagenesis, but is also mutagenic to mammalian host cells 2/
#rNHC has powerful in vitro and in vivo activity against a large number of highly pathogenic emerging RNA viruses and represents a potentially important drug for use in the current and future pandemics. 3/